About AVT
Browse Articles
Authors
Customer Services

Advanced Publication

Antiviral Therapy publishes articles here before they are finally assigned to an issue. The articles are listed by online publication date and can be cited via a doi.
 
Displaying 60 results:

Short communication

Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects: an Italian cohort

Amedeo F Capetti, Giancarlo Orofino, Gaetana Sterrantino, Maria V Cossu, Giovanni Cenderello, Anna M Cattelan, Giuseppe V De Socio, Stefano Rusconi, Niccolò Riccardi, Gian M Baldin, Serena Cima, Fosca P Niero, Giuliano Rizzardini, Lolita Sasset

10.3851/IMP3095


Original article

Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s

Theodoros Kelesidis, Thuy Tien T Tran, Todd T Brown, Carlee Moser, Heather J Ribaudo, Michael P Dube, Otto O Yang, Grace A McComsey, James H Stein, Judith S Currier

10.3851/IMP3093


Correction

Correction: Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis

Hussien Ahmed, Ahmed Elgebaly, Abdelrahman Ibrahim Abushouk, Ali Mohamed Hammad, Attia Attia, Ahmed Negida

10.3851/IMP3092


Original article

Incidental findings on chest computed tomography are common and linked to inflammation in HIV-infected adults

Michelle S Park, Corrilynn O Hileman, Abdus Sattar, Robert Gilkeson, Grace A McComsey

10.3851/IMP3090


Original article

Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons

Luther Gwaza, John Gordon, Jan Welink, Henrike Potthast, Hubert Leufkens, Matthias Stahl, Alfredo García-Arieta

10.3851/IMP3089


Original article

Factors associated with HBV virological breakthrough

Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Amany Zekry, Gregory J Dore, Jacob George, Lisa Maher

10.3851/IMP3087


Original article

Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy

Eiichi Ogawa, Norihiro Furusyo, Masayuki Murata, Motohiro Shimizu, Kazuhiro Toyoda, Taeko Hotta, Takeshi Uchiumi, Jun Hayashi

10.3851/IMP3085


Original article

Duration of first-line antiretroviral therapy in HIV-infected treatment-naive patients in routine practice

Thomas Tesson, Mathieu Blot, Aurélie Fillion, Hama Djerad, Joséphine Cagnon-Chapalain, Aline Creuwels, Anne Waldner, Michel Duong, Marielle Buisson, Sophie Mahy, Pascal Chavanet, Lionel Piroth

10.3851/IMP3084


Original article

Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis

Hussien Ahmed, Ahmed Elgebaly, Abdelrahman Ibrahim Abushouk, Ali Mohamed Hammad, Attia Attia, Ahmed Negida

10.3851/IMP3083


Short communication

Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results

Celia Oldenbuettel, Eva Wolf, Ayla Ritter, Sebastian Noe, Silke Heldwein, Rita Pascucci, Carmen Wiese, Ariane Von Krosigk, Eva Jaegel-Guedes, Hans Jaeger, Annamaria Balogh, Christine Koegl, Christoph D Spinner

10.3851/IMP3082


Page:
Copyright © Nucleus Global 2016. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.